α-Amylase/α-Glucosidase-IN-15

α-Amylase/α-Glucosidase-IN-15

• UNSPSC Description: α-Amylase/α-Glucosidase-IN-15 (compound 6C) is an oral bioactive inhibitor of α-Glucosidase and α-amylase, with the IC50s of 21 μM and 61 μM, respectively[1].
• Target Antigen: Amylases; Glycosidase
• Type: Reference compound
• Related Pathways: Metabolic Enzyme/Protease
• Field of Research: Metabolic Disease
• Assay Protocol: https://www.medchemexpress.com/α-amylase-α-glucosidase-in-15.html
• Smiles: CCOC1=CC=C(NC(CSC2=NN=C(CCN3C(C=CC=C4)=C4C5=C3C=CC=C5)O2)=O)C=C1
• Molecular Weight: 472.56
• References & Citations: [1]"Shuang Luo, et al. Novel carbazole-oxadiazole derivatives as anti-α-glucosidase and anti-α-amylase agents: Design, synthesis, molecular docking, and biological evaluation. Eur J Med Chem . 2024 Sep 5:275:116600. "
• Shipping Conditions: Room temperature
• Clinical Information: No Development Reported